Navigation Links
Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
Date:3/19/2008

(1) Kortke H, Minami K, Breymann T, et al. INR self-management after

mechanical heart valve replacement: ESCAT. Z Kardiol. 2001;90 (6)118-

124.

(2) CoaguChek XS system package insert. Indianapolis, IN. Roche

Diagnostics Corporation; 2006.

(3) Bussey HI, Chiquette E, Bianco TM, et al. A statistical and clinical

evaluation of fingerstick and routine laboratory prothrombin time

measurements. Pharmacotherapy. 1997;17(5): 861-866.

(4) Kaatz SS, White RH, Hill J, et al. Accuracy of laboratory and portable

monitor international normalized ratio determinations. Comparison with

a criterion standard. Arch Intern Med. 1995;155:1861-1867.

(5) Second Quarter 2007 total market share of projected distributor unit

sales of the Point of Care Testing Coagulation Reagents and Kits

product class by HPIS Market Intelligence, a division of GHX Global

Healthcare Exchange.

All trademarks used or mentioned in this release are legally protected by law.

For further information, please contact:

Media: Healthcare Professionals and Patients:

Lori McLaughlin

Corporate Communications

Roche Diagnostics Corporation,

Indianapolis, Ind.

Phone: 317-521-3112 Phone : 1-800-852-8766

lori.mclaughlin@roche.com Option 2 for Healthcare Professionals

and Option 4 for Patients


'/>"/>
SOURCE Roche Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
2. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
3. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
4. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
5. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
6. FluoroPharma Announces Commencement of Phase I Clinical Trial for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
7. Emisphere Announces Second Study Demonstrating Dramatic Increases in Absorption of Oral B12 Using eligen(R) Technology at Lower Doses
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Genaera Announces MedImmune Initiation of Phase 2a Trial of Antibody Targeting Interleukin-9 in Patients with Asthma
10. Micromet Announces Presentation of Five Posters Related to Its Proprietary BiTE Antibody Platform at Annual Meeting of American Association for Cancer Research
11. Nuvelo Announces Phase 2 SONOMA-3 Trial Did Not Meet Target Product Profile and Discontinues Alfimeprase Development

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., FollowingtheFDAapprovalsoftwonewtherapiesforN...havebeenupdatedtoincludeofatumumab(Azerra(TM),Glax...lymphocyticleukemia(CLL)andromidepsin(Istodax(R),G...atientswithcutaneousT-celllymphoma(CTCL). ,, FO...orecentFDAapprovalshavepromptedtheNationalComprehe...
(Date:11/23/2009)..., NEWYORK,Nov.23/PRNewswire/--Reportlinker.coma...tscatalogue. ,, AnesthesiaDisposables-AWorldMa...164276/Anesthesia-Disposables---A-World-Market-Rev...mp;utm_campaign=prnewswire ,, Globalgeneral...egreeofsaturation.Despitetheconsiderablerisewitnes...
(Date:11/23/2009)..., THEWOODLANDS,Texas,Nov.23/PRNewswire-FirstCal...nnouncedtodaythattop-linedatafromitsPhase2clinical...itablebowelsyndrome(IBS)willbepresentedatGASTRO200...significantimprovementinIBSsymptoms,willbepresente...ofclinicaldevelopment,onNovember25,2009at2:30pmloc...
Breaking Medicine Technology:NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 2NCCN Updates NHL Guidelines to Incorporate FDA Approvals of New Treatment Options 3Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Deere 26amp 3B Company Pleased With Court Ruling Concerning Retiree Health Care 59682 1Deere 26amp 3B Company Pleased With Court Ruling Concerning Retiree Health Care 59682 2Cellu Tissue Holdings Inc Files Registration Statement for Proposed Initial Public Offering of Common Stock 14515 1Cellu Tissue Holdings Inc Files Registration Statement for Proposed Initial Public Offering of Common Stock 14515 2FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 1FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 2FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 3FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 4FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 5FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 6FDA Approves Elitek 28R 29 28rasburicase 29 for Management of Plasma Uric Acid Levels in Adults with Leukemia Lymphoma and Solid Tumors Receiving A 5545 7
(Date:11/23/2009)...idualsintheRecommendedPriorityGroups ,, HARRISB...mentofHealthannouncedtodaytheywillconductthreeaddi...ersinDelaware,Lancaster,andLehighcountiesonTuesday...ministeredforfreetoindividualsintherecommendedtarg...hedepartmentasksthatonlyindividualsinthefollowingg...
(Date:11/23/2009)...n who don,t access health care from the same place...more likely to have unmet health care needs compar...ed in the journal Pediatrics . , Studies like ...livery of quality health care for children, the re...tes about health insurance reform, much of the foc...
(Date:11/23/2009)...mo deal with insomnia, study shows , , M...eep disorders affect more than three-quarters of c...rly three times higher than that of the general po...ore common in younger patients and in those with l...er Medical Center researchers, who assessed sleep ...
(Date:11/23/2009)...ksin Washington D.C. , NewYorkCity , LosAn...micGrowthandRevitalization ,, WASHINGTON,Nov.2...adingproviderofdialysisservices,todaywaslaudedbyD....millioninvestmentinIndustrialBankaspartofaninitiat...Vita,sinvestmentinWashington,D.C.ispartofthedialys...
(Date:11/23/2009)...mSupportsFutureLeadersinSTEMFields ,, Scholar...n ceS c holars.org ,, WASHINGTON,No...ountusin.Withourcommunity,foundation,andcorporatep...ate,"saidAdolphP.Falcon,SeniorVicePresidentoftheNa...teHousemeetingtodaywherePresidentObamaannouncedthe...
Breaking Medicine News(10 mins):Health News:Pennsylvania Department of Health Announces Additional H1N1 Vaccination Clinics in Delaware, Lancaster, Lehigh Counties 2Health News:Children who lack continuity with a regular health care provider miss needed services 2Health News:Children who lack continuity with a regular health care provider miss needed services 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:Alliance Joins President Obama at White House in Commitment to Science, Technology, Engineering, and Math (STEM) Education 2
... Oswego,s The Stafford opens its doors for tours o...arch 6, LAKE OSWEGO, Ore., Feb. 20 , Who/What: ...nity celebrates its grand opening with...imary School Choir and noted Musicians...
...ffordable dental/health care initiative to put an ...cy Dentist 24/7(TM),cutting edge health care model...nding its program, the first of its kind, by offer...ncing,affordable dental/health care available ever...
...ation, wealth play big part in downward trend, stu...Day News) -- Memory loss and thinking problems are...bly due to better education, personal wealth and c...older found the rate of cognitive impairment (the ...
...cientists know exposure to low levels of lead can ...guage impairments and vision loss, but a newly dis...men, according to a University of Houston professo...hile studying the effects of lead on the retina in...
...y finds enhanced alertness, mood in those who list... Feb. 20 (HealthDay News) -- Listening to music fo...t,s early recovery, according to Finnish researche... for a few hours a day showed better improvements ...
...ou may not be aware of it - they might not be awar...ight be slowing you down. , New research by Unive...r Dr. Tim Welsh says that regardless of their inte...ituation like a complex assembly line, said Welsh ...
Other Medicine News:Health News:Upscale Yet Affordable Housing Sets New Standard for Seniors 2Health News:Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program 2Health News:Cognitive Impairment Declining in Older Adults 2Health News:Warning: Expert at UH adds obesity to side effects of lead exposure 2Health News:Music Therapy Improves Stroke Outcomes 2Health News:Who's slowing you down? 2
Gentamicin, 50 mg/ml
GENTAMICIN SULFATE, 1000X
...e is effective against gram positive and gram nega...ng with bacterial protein synthesis by binding to ...g concentration of 50 mg/L is generally non-toxic ...entler alternative to penicillin and steptomycin. ...
Gibco Gentamicin Reagent Solution (10 mg/ml) liquid
Medicine Products: